When a new drug gets tested, the results of the trials should be published for the rest of the medical world.
Except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark.
In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
In a cohort study reported in JAMA Internal Medicine, Reimers et al found that aspirin use was associated with a significant 47% reduction in mortality risk after diagnosis of colon cancer expressing HLA class I antigen.
Lung cancer is now the second leading cause of cancer death in women worldwide. An estimated 491,200 women died of lung cancer in 2012, more than half (57%) of whom resided in economically developing countries. Differences in smoking patterns account for much of the variation in lung cancer rates around the globe.
Deutsch
Nederlands
Turkish
Russian
Italiano
Français
Português
العربية